What Is Thrombosis?

Thrombosis is the pathological formation of a blood clot, called a thrombus, within a blood vessel or the heart, obstructing normal blood flow. While the body's hemostatic system relies on controlled clot formation to seal wounds and prevent blood loss, thrombosis occurs when this process is triggered inappropriately or becomes unregulated, potentially blocking the vessel entirely. The condition underlies major cardiovascular events including deep vein thrombosis, pulmonary embolism, myocardial infarction, and ischemic stroke, making it one of the leading causes of morbidity and mortality worldwide.

Thrombosis sits at the intersection of hematology, vascular biology, and biomedical engineering. Engineers and clinical researchers study it quantitatively to understand how fluid forces, vessel geometry, blood cell mechanics, and biochemical cascades interact in producing clots. This quantitative perspective has driven the development of computational models, microfluidic test platforms, and biomaterial design criteria for implanted medical devices.

Mechanisms of Clot Formation

Thrombus formation involves two overlapping processes: primary hemostasis, driven by platelet aggregation, and secondary hemostasis, driven by the coagulation cascade. Vascular injury exposes collagen and von Willebrand factor beneath the endothelium, which recruit circulating platelets through specific receptor-ligand interactions. Platelets that adhere to the injury site become activated, release chemical signals that recruit additional platelets, and begin aggregating into a soft platelet plug. Simultaneously, tissue factor exposed at the injury site initiates the coagulation cascade, a series of serine protease reactions that culminates in the conversion of fibrinogen to fibrin through the action of thrombin. Fibrin strands cross-link the platelet plug into a stable clot. Venous thrombi are typically fibrin-rich, while arterial thrombi are platelet-dominant, a distinction that has direct implications for anticoagulant versus antiplatelet therapy choices.

Fluid Mechanics and Hemodynamic Factors

Blood flow exerts a determining influence on where and how thrombi form. Research on the fluid mechanics of blood clot formation shows that red blood cells, which occupy roughly 45% of blood volume, push the smaller platelets toward vessel walls through a phenomenon called margination, concentrating platelets near the endothelium where they are most needed for hemostatic response. High shear rates at arterial constrictions activate von Willebrand factor, which unfolds under flow stress to present platelet-binding sites that remain hidden under normal conditions. Regions of flow recirculation and stagnation, such as those downstream of stenoses or around prosthetic heart valve leaflets, predispose to clot growth by allowing activated clotting factors to accumulate locally rather than being washed away. These observations have shaped the design rules for cardiovascular implants and blood-contacting devices.

Biomedical Engineering and In Vitro Models

The engineering of accurate in vitro thrombosis models has become an active field because animal models often do not replicate human coagulation biology faithfully. Microfluidic thrombosis-on-a-chip platforms recreate vascular structures lined with human endothelial cells, allowing researchers to observe platelet aggregation and fibrin formation in real time under controlled flow conditions. These systems enable drug screening and the testing of biomaterial hemocompatibility at scales and throughputs impossible with animal experiments. Computational models of thrombosis combine fluid dynamics solvers with biochemical reaction networks to predict clot growth in patient-specific geometries reconstructed from medical imaging. Standards for testing the thrombogenicity of medical devices, including blood pumps, stents, and catheters, are defined by ISO 10993-4, which specifies the hemocompatibility evaluation framework used globally.

Applications

Thrombosis has applications in a wide range of fields, including:

• Design and hemocompatibility testing of cardiovascular implants, including stents and heart valves
• Development of anticoagulant and thrombolytic drug therapies
• Risk stratification algorithms for patients with atrial fibrillation
• Blood-contacting surface engineering for extracorporeal circuits and dialysis membranes
• Computational hemodynamics modeling for surgical planning